Imed Infinity Medical-Limited Partnership

TASE:IMED Stock Report

Market Cap: ₪4.5m

Imed Infinity Medical-Limited Partnership Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Itay Gal-Or

Chief executive officer

US$142.2k

Total compensation

CEO salary percentage100.0%
CEO tenureno data
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Itay Gal-Or's remuneration changed compared to Imed Infinity Medical-Limited Partnership's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$1m

Mar 31 2024n/an/a

-US$1m

Dec 31 2023US$142kUS$142k

-US$2m

Sep 30 2023n/an/a

-US$2m

Jun 30 2023n/an/a

-US$1m

Mar 31 2023n/an/a

-US$1m

Dec 31 2022US$16kUS$16k

-US$1m

Compensation vs Market: Itay's total compensation ($USD142.21K) is below average for companies of similar size in the IL market ($USD423.97K).

Compensation vs Earnings: Itay's compensation has increased whilst the company is unprofitable.

CEO

Itay Gal-Or (41 yo)

no data

Tenure

US$142,209

Compensation

Mr. Itay Gal-Or is Acting Chief Executive Officer of Imed Infinity Medical General Partner Ltd of Imed Infinity Medical-Limited Partnership. He has an extensive global background with experience in the are...

Leadership Team

NamePositionTenureCompensationOwnership
Itay Gal-Or
Acting Chief Executive Officer of Imed Infinity Medical General Partner Ltdno dataUS$142.21kno data
Chanan Morris
CFO & COO of Imed Infinity Medical General Partner Ltd4.3yrsUS$80.23kno data
Einav Brar
Director & Partner of Imed Infinity Medical General Partner Ltdless than a yearno datano data
Dan Suesskind
Director & Partner of Imed Infinity Medical General Partner Ltdless than a yearno datano data

0.9yrs

Average Tenure

56yo

Average Age

Experienced Management: IMED's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Einav Brar
Director & Partner of Imed Infinity Medical General Partner Ltd4yrsno datano data
Dan Suesskind
Director & Partner of Imed Infinity Medical General Partner Ltd3.3yrsno datano data
Yahel Shachar
Independent Outside Director of Imed Infinity Medical General Partner Ltd3.8yrsno datano data
Rivka Carmi
Independent Director of Imed Infinity Medical General Partner Ltd4yrsno datano data
Yehoshua Abramovich
Chairman of Imed Infinity Medical General Partner Ltd4yrsUS$31.82k0.53%
₪ 23.6k
Iris Loewenstein
Independent Outside Director of Imed Infinity Medical General Partner Ltd3.5yrsno datano data

3.9yrs

Average Tenure

64.5yo

Average Age

Experienced Board: IMED's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 12:26
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Imed Infinity Medical-Limited Partnership is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution